660 Shares in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Acquired by Union Bancaire Privee UBP SA

Union Bancaire Privee UBP SA bought a new stake in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 660 shares of the company’s stock, valued at approximately $42,000.

Several other large investors have also recently made changes to their positions in IHE. US Bancorp DE boosted its position in shares of iShares U.S. Pharmaceuticals ETF by 137.0% in the 3rd quarter. US Bancorp DE now owns 384 shares of the company’s stock worth $27,000 after purchasing an additional 222 shares in the last quarter. Assetmark Inc. boosted its holdings in iShares U.S. Pharmaceuticals ETF by 100.0% in the third quarter. Assetmark Inc. now owns 432 shares of the company’s stock worth $31,000 after acquiring an additional 216 shares in the last quarter. Allworth Financial LP grew its stake in shares of iShares U.S. Pharmaceuticals ETF by 9.4% during the third quarter. Allworth Financial LP now owns 1,853 shares of the company’s stock worth $131,000 after acquiring an additional 159 shares during the last quarter. EP Wealth Advisors LLC acquired a new position in shares of iShares U.S. Pharmaceuticals ETF during the third quarter valued at about $157,000. Finally, Farther Finance Advisors LLC raised its position in shares of iShares U.S. Pharmaceuticals ETF by 97.1% in the 3rd quarter. Farther Finance Advisors LLC now owns 2,482 shares of the company’s stock valued at $175,000 after purchasing an additional 1,223 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Trading Up 0.2 %

NYSEARCA:IHE opened at $69.26 on Thursday. The company’s 50 day moving average is $67.21 and its two-hundred day moving average is $69.04. The company has a market cap of $699.53 million, a PE ratio of 6.49 and a beta of 0.58. iShares U.S. Pharmaceuticals ETF has a twelve month low of $62.67 and a twelve month high of $72.94.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.